Catalyst

Slingshot members are tracking this event:

FDA Approves Gilead's (GILD) Single Tablet Regimen Genvoya for Treatment of HIV-1 Infection

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
GILD

100%
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 05, 2015
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Genvoya, Hiv-1, Acquire